Copyright
©The Author(s) 2019.
World J Psychiatr. Jan 4, 2019; 9(1): 7-29
Published online Jan 4, 2019. doi: 10.5498/wjp.v9.i1.7
Published online Jan 4, 2019. doi: 10.5498/wjp.v9.i1.7
Any anxiety disorder | Individual anxiety disorders | |
Stanley foundation studies | ||
McElroy et al[100], 2001 (n = 288) | Lifetime rate 42%; Current rate 30% | PD lifetime 20%, current 9%; SOC PHOBIA lifetime 16%, current 13%; SP PHOBIA lifetime 10%, current 8%; OCD lifetime 9%, current 8%; PTSD lifetime 7%, current 4%; GAD lifetime 3%, current 3% |
Suppes et al[101], 2001 (n = 261) | Lifetime rate 44% | |
Dittmann et al[102], 2002 (n = 152) | Lifetime rate 12% | |
Levander et al[103], 2007 (n = 350) | Lifetime rate BD 46%; BP I 45%-48%; BP II 38%-58% | |
Altshuler et al[104], 2010 (n = 711) | Lifetime rate: women 46%, men 29% | Lifetime rates: PD women 21%, men 14%; SOC PHOBIA women 12%, men 10%; SP PHOBIA women 12%, men 4%; OCD women 12%, men 7%; PTSD women 11%, men 3%; AGORA women 3%, men 2% |
STEP-BD | ||
Kogan et al[105], 2004 (n = 1000) | Lifetime rate 47% | |
Perlis et al[106], 2004 (n = 983) | Prevalence rate 38%-69% | SOC PHOBIA 13%-31%, GAD 13%-29%, PD 14%-27%, PTSD 11%-27%, OCD 8%-13%, AGORA 5%-11% |
Simon et al[107], 2004 (n = 475) | Lifetime rate BD 51%; BP I/BP II 53%/46%; Current BD 30%; BP I/BP II 34%/19%; | Lifetime BD: SAD 22%, GAD 18%, PD 17%, PTSD 17%, OCD 10%, AGORA 8%; current BD: SAD 13%, PD 8%, OCD 6%, PTSD 5%, AGORA 4%, GAD 2% |
Simon et al[108], 2004 (n = 919) | Current rate 32% | GAD 13%, SAD 13%, PD 8%, OCD 7%, PTSD 5%, AGORA 4% |
Otto et al[109], 2006 (n = 1000) | Current rate 32% | Current rates: SAD 13%, GAD13%, PD 8%, OCD 7%, PTSD 5%, AGORA 4% |
Simon et al[110], 2007 (n = 120) | Lifetime rate 62%; current rate 29% | GAD lifetime 31%, current 13%; SAD lifetime 27%, current 14%; PD lifetime 22%, current 5%; PTSD lifetime 27%, current 11%; OCD lifetime 11%, current 6%; AGORA lifetime 9%, current 2% |
Other studies | ||
Vieta et al[111], 2001 (n =129) | PD 2%, SOC PHOBIA 2%, SP PHOBIA 2%, OCD 2% | |
MacKinnon et al[112], 2002 (n = 192) | Prevalence PD 14% | |
Henry et al[113], 2003 (n = 318) | Lifetime rates 24% | Lifetime rates: PD 16%, PHOBIAS 11%, OCD 3% |
Boylan et al[114], 2004 (n = 138) | Prevalence 56% | |
Bauer et al[14], 2005 (n = 328) | Lifetime rate 43%; current rate 38% | PTSD lifetime 28%, current 25%; PD lifetime 20%, current 17%; OCD lifetime 11%, current 8% |
Mantere[28], 2007 (n = 191) | Lifetime rate: BD 53%, BP I 46%, BP II 60%; current rate: BD 45%, BP I 36%, BP II 52% | PD lifetime 32%, current 24%; SOC PHOBIA lifetime 26%, current 18%; PTSD lifetime 16%, current 10%; GAD lifetime 15%; SP PHOBIA lifetime 8%, current 8%; OCD lifetime 5%, current 2%; AGORA lifetime 3%, current 2% |
Azorin et al[115], 2009 (n = 1090) | Lifetime rate 27% | Lifetime rates: GAD 20%, PD 5%, AGORA 4%, SOC PHOBIA 2%, PTSD 2%, OCD 1.5% |
Coryell et al[116], 2009 (n = 259) | Lifetime rates: PHOBIA 3%-6%, GAD 1%-5%, PD 1%-4%, OCD 2% | |
Gao et al[117], 2010 (n = 564) | Prevalence in RCBD 46% | |
Guo et al[118], 2010 (n = 136763) | Prevalence 36%-37% | |
Mantere et al[119], 2010 (n =191) | Current rate 31%-44% | |
Fracalanza et al[120], 2011 (n = 186) | Current rate 33% | Current rates: SAD 39%, PD 31%, OCD 16%, GAD 10%, PTSD 3% |
Goes et al[121], 2012 (n = 1416) | Prevalence: PD 23%, SP PHOBIA 10%, SOC PHOBIA 8%, OCD 6% | |
Chang et al[122], 2012 (n = 325) | Lifetime rates: BP I 27%, BP II 39% | Lifetime rates (BPI/BP II): GAD 10%/29%, PD 5%/9%, SOC PHOBIA 4%/5%, PTSD 3%/2%, OCD 2%/4%, SP PHOBIA 1%/4% |
Angst et al[123], 2013 (n = 903) | Mean prevalence: BP I 17%; BP II 27% | Mean prevalence (BP I/BP II): GAD 6%/12%, PD 12%/18%, SOC PHOBIA 5%/8%, OCD 6%/11% |
Castilla-Puentes et al[124], 2013 (n = 8129 youth) | Prevalence: Non RCBD 51%; RCBD 65%; BP I 41%-65%; BP II 69%-75%; | Prevalence (RCBD): GAD 55%, SAD 44%, OCD 11%, PTSD 9%, PD 9%, SP PHOBIA 8% |
Young et al[125], 2013 (n = 304) | Lifetime rate 22% | PD 40%, SP PHOBIA 24%, OCD 15%, GAD 13%, SAD 10%, AGORA 8% |
Asaad et al[126], 2014 (n = 350) | Prevalence 2.3% | |
Baek et al[127], 2014 (n = 417) | Lifetime rate 30% | Lifetime rates: PD 13%, SP PHOBIA 13%, OCD 13%, SOC PHOBIA 9% |
- Citation: Spoorthy MS, Chakrabarti S, Grover S. Comorbidity of bipolar and anxiety disorders: An overview of trends in research. World J Psychiatr 2019; 9(1): 7-29
- URL: https://www.wjgnet.com/2220-3206/full/v9/i1/7.htm
- DOI: https://dx.doi.org/10.5498/wjp.v9.i1.7